Business
Ventripoint to Sponsor the Annual Meeting of the British Congenital Cardiac Association
(TheNewswire) Toronto, Ontario – TheNewswire – November 4, 2022 - V...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint to Sponsor the Annual Meeting of the British Congenital Cardiac Association\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Toronto, Ontario – TheNewswire –\nNovember 4, 2022\n \n \n - Ventripoint Diagnostics Ltd.\n(\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \"), (TSXV:VPT\n \n \n )\n \n \n ;\n \n \n (\n \n \n OTC:VPTDF) is pleased to announce that it will be a gold\nsponsor for the 2022 Annual Scientific Meeting of the British\nCongenital Cardiac Association (BCCA).  Dr. Gregory Skinner, a\nClinical Advisor to the Company, will be giving a presentation that\nwill highlight the use of the VMS+3.0 in retrieving volumetric and\nfunctional data for managing cardiac heart disease patients.\n \n \n \n \n The meeting will take place on Monday 7\n \n \n th\n \n \n and Tuesday\n8\n \n \n th\n \n \n of November 2022 at the International Conference Centre in Birmingham,\nUK. The BCCA meeting attracts over 400 delegates from across the UK\nand worldwide with a focus in adult and paediatric congenital\ncardiology. The attendees will be members of various cardiac\nassociations and health care professionals, which each year creates a\nvaluable networking experience.\n \n \n \n \n Dr. Skinner’s presentation will take place on\nNovember 8\n \n \n th\n \n \n , 2022 and is entitled: “Accurate, Reproducible Volumetric\nand Functional Data for Managing Congenital Heart Disease Using VMS\nFrom Ventripoint”.  The presentation will focus on the unique\nabilities of the VMS+3.0 in the management of congenital cardiac\npatients through case studies and real-life examples.\n \n \n \n \n Exhibiting at the BCCA meeting continues\nVentripoint’s ongoing efforts to make the cardiology community aware\nof the benefits of the VMS+3.0 and allow them to have a hands-on\nexperience of the ease of use of the system in the exhibition booth\nand then schedule an on-site demonstration at their clinic.\n \n \n \n \n About Ventripoint Diagnostics\nLtd.\n \n \n \n \n Ventripoint\n \n \n has become an\nindustry leader in the application of AI (Artificial Intelligence) to\nechocardiography. Ventripoint's VMS products are powered by its\nproprietary KBR technology, which is the result of a decade of\ndevelopment and provides accurate volumetric cardiac meas...